ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity

[1]  O. Kallioniemi,et al.  Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention , 2022, Cell Death & Disease.

[2]  M. Varjosalo,et al.  New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome , 2022, Cellular and Molecular Life Sciences.

[3]  Min Li,et al.  The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis , 2021, Journal of Ovarian Research.

[4]  Katja Kaipio,et al.  PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples , 2021, Bioinform..

[5]  A. Bleckmann,et al.  The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention , 2021, Cells.

[6]  K. Nyangoh Timoh,et al.  The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer , 2020, Journal of clinical medicine.

[7]  S. Knapp,et al.  Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases. , 2020, Molecular cell.

[8]  A. Regev,et al.  A single-cell landscape of high-grade serous ovarian cancer , 2020, Nature Medicine.

[9]  Y. Kakeji,et al.  Mesenchymal stem cell‐derived CXCL16 promotes progression of gastric cancer cells by STAT3‐mediated expression of Ror1 , 2020, Cancer science.

[10]  R. Jain,et al.  A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.

[11]  B. Davidson,et al.  Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma , 2020, Virchows Archiv.

[12]  Emanuela M. Ghia,et al.  Cirmtuzumab Blocks Wnt5a/ROR1-Stimulation Of NF-κB To Repress Autocrine STAT3-Activation In Chronic Lymphocytic Leukemia. , 2019, Blood.

[13]  H. Kohler,et al.  Glucocorticoids promote breast cancer metastasis , 2019, Nature.

[14]  Harlan R. Barker,et al.  Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting , 2019, Oncogene.

[15]  M. Nykter,et al.  Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies1 , 2018, Translational oncology.

[16]  E. Llamosas,et al.  ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. , 2018, Gynecologic oncology.

[17]  C. Ford,et al.  Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer1 , 2017, Translational oncology.

[18]  P. Goodfellow,et al.  Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target , 2017, Oncogene.

[19]  M. Boutros,et al.  Wnt signaling in cancer , 2016, Oncogene.

[20]  E. Llamosas,et al.  Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer , 2016, Oncogenesis.

[21]  V. Beral,et al.  Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.

[22]  E. Ghia,et al.  Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy , 2014, Proceedings of the National Academy of Sciences.

[23]  L. Trusolino,et al.  The ROR1 pseudokinase diversifies signaling outputs in MET‐addicted cancer cells , 2014, International journal of cancer.

[24]  Hua Yu,et al.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.

[25]  E. Llamosas,et al.  The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. , 2014, Gynecologic oncology.

[26]  C. Sander,et al.  Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.

[27]  G. Mills,et al.  Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth , 2011, Nature Medicine.

[28]  Z. Estrov,et al.  Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells , 2010, PloS one.

[29]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[30]  Ben S. Wittner,et al.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.